HOLKIRA

Marca svizra · 657658 · Marca da pled · Stizzada

Inscripziun en il register

Numer da registraziun
657658
Numer da la dumonda
51118/2014
Status
Stizzada
Tip
Marca da pled
Deponida
29-01-2014
Registrada
22-04-2014
Publitgada
22-04-2014
Stizzada
22-08-2024
Motiv
Betg prolungada
Prioritad
15.08.2013 US
Lingua da la procedura
tudestg
Funtauna
Swissreg

Products e servetschs

Pharmaceuticals

Pharmazeutische Präparate zur Behandlung von Hepatitis C.

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 22-08-2024

    Stritgà, betg prolungà

    Status of protective title
    Active → Cancelled
    Cancellation date
    22.08.2024
    Cause for cancellation
    Cancellation due to non-renewal

    Published in Swissreg on 22.08.2024

  2. 15-01-2024

    Curregì

    Owner
    AbbVie Manufacturing Management Unlimited Company, 70 SirJohn Rogerson¿s Quay, Dublin 2, Ireland → AbbVie Manufacturing Management Unlimited Company, 70 Sir John Rogerson's Quay, Dublin 2, Ireland
    Representative
    Baker McKenzie Zurich, Holbeinstrasse 30, Postfach, 8034 Zürich → Baker McKenzie Switzerland AG, Holbeinstrasse 30, 8034 Zurich

    Published in Swissreg on 15.01.2024

  3. 12-01-2024

    Represchentant stritgà

    Representative
    Baker & McKenzie Zurich, Holbeinstrasse 30, 8034 Zürich (allontanà)

    Published in Swissreg on 12.01.2024

  4. 12-01-2024

    Transferì

    Owner
    AbbVie Ireland Unlimited Company, 2 Church Street, Hamilton HM 11, Bermuda → AbbVie Manufacturing Management Unlimited Company, 70 SirJohn Rogerson¿s Quay, Dublin 2, Ireland
    Representative
    Baker McKenzie Zurich, Holbeinstrasse 30, Postfach, 8034 Zürich

    Published in Swissreg on 12.01.2024

  5. 30-01-2019

    Transferì

    Owner
    AbbVie Inc., 1 North Waukegan Road, North Chicago, IL 60064, USA → AbbVie Ireland Unlimited Company, 2 Church Street, Hamilton HM 11, Bermuda

    Published in Swissreg on 30.01.2019

  6. 17-03-2015

    Stritgà per part

    LGS
    5, Pharmazeutische Präparate und Substanzen zur Behandlung von viralen, metabolischen, endokrinen, muskuloskelettalen, kardiovaskulären, kardiopulmonalen, urogenitalen, onkologischen, hepatologischen, ophthalmischen, respiratorischen, neurologischen, gastrointestinalen, hormonellen, dermatologischen, psychiatrischen und das Immunsystem sowie sexuelle Dysfunktion betreffenden Erkrankungen und Störungen; Impfstoffe. → 5, Pharmazeutische Präparate zur Behandlung von Hepatitis C.
    International classification
    5 → 5

    Published in Swissreg on 17.03.2015

  7. 22-04-2014

    Registrà

    Published in Swissreg on 22.04.2014

Partidas

Il register numna mintga partida cun num ed adressa. Ina partida è colliada cun ina unitad, sch’exactamain ina unitad dal register da commerzi porta ses num; la via d’ina partida betg uschia renconuschida na vegn betg mussada qua.